SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-010827
Filing Date
2021-05-10
Accepted
2021-05-10 06:31:01
Documents
69
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 720105
2 ex31-1.htm EX-31.1 8004
3 ex31-2.htm EX-31.2 7919
4 ex32-1.htm EX-32.1 5179
5 image_001.jpg GRAPHIC 4853
  Complete submission text file 0001493152-21-010827.txt   4301848

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE mtnb-20210331.xsd EX-101.SCH 40584
7 XBRL CALCULATION FILE mtnb-20210331_cal.xml EX-101.CAL 52353
8 XBRL DEFINITION FILE mtnb-20210331_def.xml EX-101.DEF 139314
9 XBRL LABEL FILE mtnb-20210331_lab.xml EX-101.LAB 329146
10 XBRL PRESENTATION FILE mtnb-20210331_pre.xml EX-101.PRE 247898
11 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 602859
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-484-8805
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38022 | Film No.: 21905145
SIC: 2834 Pharmaceutical Preparations